| Effect | Decrease |
| Values | Beck. Mean and SD. Placebo: before 23.5 ± 2.6, after 21.3 ± 2.6. Carnitine: before 23.6 ± 2.8, after 18 ± 3.5 |
| Trial Design | Double blind |
| Trial Length | n/a |
| Number of Subjects | 67 |
| Sex | n/a |
Acetyl-L-Carnitine at 4g a day (2g, twice a day) was associated with decreased depression and improved quality of life as a result of hepatic encepalopathy.
